Prevent and Therapeutic Antitumor Response to Cervical Cancer in Mice Immunized with U14 Cell Vaccines Transfected with Costimulatory B7 Gene and HPV16E6/B7 DNA Recombinant Vaccines
[Results] Among major sites, female breast cancer experienced a highest 5-year survival (OS: 55.92%, RS: 58.44%), followed by cervix cancer (OS: 39.06, RS: 42.40%).
The positive rates of PTEN protein in uterine cervix cancer and normal tissue closely adjacent to carcinoma were 40% (19/48) and 96% (46/48), and the difference was significant (P<0.05).
Loss of heterozygosity (LOH) analysis on chromosome 6 was performed to define the genetic changes that occur in the development of squamous cell cervical cancer (SCC).
The results of the works carried out in the Laboratory of Molecular Biology of Viruses, CRC in the framework of the Human Genome program and devoted to the study of the activity of cell and viral genes in cervical cancer are summarized.
Oncogenic human papillomaviruses (mostly HPV types 16 and 18) are the major cause of cervical intraepithelial neoplasia (CIN), which progresses into cervical cancer (CC).
Real-time PCR was used to quantitate structural and functional aberrations in the tumor suppressor gene RBSP3 (3p.21) in papillomavirus-positive cervical carcinoma (CC).
This paper presents a heat transfer model for the hyperthermia treatment of cervix cancer using a intracavitary microwave applicator and based on which the 3-D finite element simulation of the temperature fields have done.
To investigate the correlation between late rectal complications and rectal dose in cervix cancer patients treated with high-dose-rate intracavitary radiotherapy (HDR ICR) and to analyze factors reducing rectal complications.
Thrombin, factor XIII and fobroncctin were incubated with cultures of mouse sarcoma cells, human cervix carcinoma cells (HeLa cells) and cells of an acute lymphoblastic leukemia.
Thrombin, factor XIII and fibronectin were incubated with cultures of mouse sarcoma cells, human cervix carcinoma cells (HeLa cells) and cells of an acute lymphoblastic leukemia.